Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Family‐based transmission disequilibrium testing (TDT) has revealed modest biased transmission of DRD5 microsatellite alleles in ADHD. In a Turkish trio cohort (n=104), a trend for linkage and association was reported (TDT χ2=2.38, one‐tailed P=0.06) with more significant association among methylphenidate responders (PMID:10889550). A larger multiplex family study confirmed biased nontransmission of the DRD5 146-bp allele (P=0.02) (PMID:14699430). However, adult ADHD severity analyses (n=110) and a Colombian trio/case–control study (n=152) found no significant DRD5 associations (PMID:20006992; PMID:26526368). Rare copy number variants overlapping the DRD5 locus were observed in 7.7% of ADHD probands (19/248) but absent in 2,357 controls (PMID:21832240). Age at onset analyses in 229 families identified SNP haplotypes flanking DRD5 associated with earlier ADHD onset (FDR‐adjusted q<0.023) (PMID:17501935).
Overall, DRD5 associations rely on small family cohorts, common regulatory and structural variants, and lack pathogenic coding changes or segregation data. Replication is inconsistent across populations. Key Take-home: Current evidence is limited for DRD5 variants as diagnostic or predictive markers in ADHD.
Gene–Disease AssociationLimitedModest family-based associations (TDT P=0.02), CNVs in 7.7% of probands; inconsistent replication across studies Genetic EvidenceLimitedSmall TDT sample sizes (<300 trios), no coding pathogenic variants, inconsistent associations Functional EvidenceLimitedNo direct functional assays of DRD5 variants in ADHD |